共 182 条
- [11] Jeffrey SS(2008)Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer Cancer Cell 13 91-104
- [12] Rees CA(2008)Dissecting resistance to endocrine therapy in breast cancer Cell Cycle 7 1895-1898
- [13] Pollack JR(2012)Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells Oncogene 31 3845-3856
- [14] Ross DT(2013)Knockdown of cyclin-dependent kinase 10 (cdk10) gene impairs neural progenitor survival via modulation of raf1a gene expression J. Biol. Chem. 288 27927-27939
- [15] Johnsen H(2012)CDK10 functions as a tumor suppressor gene and regulates survivability of biliary tract cancer cells Oncol. Rep. 27 1266-1276
- [16] Akslen LA(2012)Clinical and biological significance of Cdk10 in hepatocellular carcinoma Gene 498 68-74
- [17] Fluge O(2013)Promoter hypermethylation contributes to the frequent suppression of the CDK10 gene in human nasopharyngeal carcinomas Cell. Oncol. 36 323-331
- [18] Pergamenschikov A(2015)Elevated C1orf63 expression is correlated with CDK10 and predicts better outcome for advanced breast cancers: a retrospective study BMC Cancer 15 548-14
- [19] Williams C(2015)ECRG4 acts as a tumor suppressor and as a determinant of chemotherapy resistance in human nasopharyngeal carcinoma Cell. Oncol. 38 205-77
- [20] Zhu SX(2012)Morphogenesis and the cell cycle Genetics 190 51-2910